Figure 2 SGLT2i compared to metformin A total of three RCTs (468 belonged to the SGLT2i group and 455 to the metformin group) compared the changes in HbA1c, body weight and FPG from baseline to follow-up in patients with T2DM ( 2 = 0%) and FPG (MD: -10.13, 95% CI: -14.99, -5.27
In the Obesity Treatment Group, 979 patients were analyzed
Esta reaccin de desintoxicacin se lleva a cabo por el sistema glioxalasa
GLP-1 agonists could be the first effective treatment for OUD that does not act on the opioid receptor pathway
Source Reference: Kellner DA, et al "Effect of glucagon-like peptide 1 receptor agonists on patients with rheumatoid arthritis" ACR Open Rheumatol 2025
Flynn E, Tanigawa Y, Rodriguez F, Altman RB, Sinnott-Armstrong N, Rivas MA